InvestorsHub Logo
Followers 13
Posts 3218
Boards Moderated 0
Alias Born 04/26/2007

Re: None

Tuesday, 02/08/2022 5:00:55 PM

Tuesday, February 08, 2022 5:00:55 PM

Post# of 40491
2/8/22 A: “I believe Advaccine is planning to go IPO this year. However, that will most likely depend on clinical progress as well as market condition. While INOVIO is not the sponsor, I did hear that heterologous boost and homologous boost trials are progressing.”

2/8/22 Q: When Will Advaccine go IPO in HK exchange this year? Will heterologous trial draw blood 2, 4, 6, 8, … in increment of 2 weeks after the booster shot?

Do you have link to homologous study?

Note: Link to heterologous booster trial updated 12/7/21
Study execute time:
From2021-12-25 To 2022-07-25
6 groups of 80 ppl each
Cohorts A have received 2 Coronavac doses within 3 mos prior.
Cohorts B have received 2 Coronavac doses within 6 mos prior.
Each cohort receives 0.5, 1, 2 mg 4800/pGX9501 or placebo
https://www.chictr.org.cn/hvshowproject.aspx?id=119337
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News